| 1 |
Thakar CV, Christianson A, Freyberg R, et al. Incidence and outcomes of acute kidney injury in intensive care units: A veterans administration study [J]. Crit Care Med, 2009, 37(9):2552-2558.
|
| 2 |
Uchino S, Kellum JA, Bellomo R, et al. Acute renal failure in critically ill patients: a multinational, multicenter study [J]. JAMA, 2005, 294(7):813-818.
|
| 3 |
Waikar SS, Liu KD, Chertow GM. Diagnosis, epidemiology and outcomes of acute kidney injury [J]. Clin J Am Soc Nephrol, 2008, 3(3):844-861.
|
| 4 |
Liano F, Pascual J. Epidemiology of acute renal failure: a prospective, multicenter, community-based study. Madrid Acute Renal Failure Study Group [J]. Kidney Int, 1996, 50(3):811-818.
|
| 5 |
Mehta RL, Pascual MT, Soroko S, et al. Spectrum of acute renal failure in the intensive care unit: the PICARD experience [J]. Kidney Int, 2004, 66(4):1613-1621.
|
| 6 |
Pino CJ, Yevzlin AS, Tumlin J, et al. Cell-based strategies for the treatment of kidney dysfunction: a review [J]. Blood Purif, 2012, 34(2):117-123.
|
| 7 |
Zarjou A, Agarwal A. Sepsis and acute kidney injury [J]. J Am Soc Nephrol, 2011, 22(6):999-1006.
|
| 8 |
Humes HD. Cell therapy: leveraging nature′s therapeutic potential [J]. J Am Soc Nephrol, 2003, 14(8):2211-2213.
|
| 9 |
Fissell WH, Humes HD. Cell therapy of renal failure [J]. Transplant Proc, 2003, 35(8):2837-2842.
|
| 10 |
Cribbs SK, Martin GS. Stem cells in sepsis and acute lung injury [J]. Am J Med Sci, 2011, 341(4):325-332.
|
| 11 |
Mei SH, Haitsma JJ, Dos Santos CC, et al. Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis [J]. Am J Respir Crit Care Med, 2010, 182(8):1047-1057.
|
| 12 |
Gupta N, Su X, Popov B, et al. Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice [J]. J Immunol, 2007, 179(3):1855-1863.
|
| 13 |
Kähler CM, Wechselberger J, Hilbe W, et al. Peripheral infusion of rat bone marrow derived endothelial progenitor cells leads to homing in acute lung injury [J]. Respir Res, 2007, 8:50.
|
| 14 |
Ding F, Humes HD. The bioartificial kidney and bioengineered membranes in acute kidney injury [J]. Nephron Exp Nephrol, 2008, 109(4):e118-e122.
|
| 15 |
Humes HD, Fissell WH, Weitzel WF. The bioartificial kidney in the treatment of acute renal failure [J]. Kidney Int Suppl, 2002, 80:121-125.
|
| 16 |
Fissell WH, Lou L, Abrishami S, et al. Bioartificial kidney ameliorates gram-negative bacteria-induced septic shock in uremic animals [J]. J Am Soc Nephrol, 2003, 14(2):454-461.
|
| 17 |
MacKay SM, Funke AJ, Buffington DA, et al. Tissue engineering of a bioartificial renal tubule [J]. ASAIO J, 1998, 44(3):179-183.
|
| 18 |
Humes HD, MacKay SM, Funke AJ, et al. Tissue engineering of a bioartificial renal tubule assist device: In vitro transport and metabolic characteristics [J]. Kidney Int, 1999, 55(6):2502-2514.
|
| 19 |
Humes HD, Buffington DA, MacKay SM, et al. Replacement of renal function in uremic animals with a tissue-engineered kidney [J]. Nat Biotechnol, 1999, 17(5):451-455.
|
| 20 |
Humes HD, Fissell WH, Weitzel WF, et al. Metabolic replacement of kidney function in uremic animals with a bioartificial kidney containing human cells [J]. Am J Kidney Dis, 2002, 39(5):1078-1087.
|
| 21 |
Humes HD, Buffington DA, Lou L, et al. Cell therapy with a tissue- engineered kidney reduces the multiple-organ consequences of septic shock [J]. Crit Care Med, 2003, 31(10):2421-2428.
|
| 22 |
Fissell WH, Dyke DB, Weitzel WF, et al. Bioartificial kidney alters cytokine response and hemodynamics in endotoxin-challenged uremic animals [J]. Blood Purif, 2002, 20(1):55-60.
|
| 23 |
Humes HD, Weitzel WF, Bartlett RH, et al. Initial clinical results of the bioartificial kidney containing human cells in ICU patients with acute renal failure [J]. Kidney Int, 2004, 66(4):1578-1588.
|
| 24 |
Tumlin J, Wali R, Williams W, et al. Efficacy and safety of renal tubule cell therapy for acute renal failure [J]. J Am Soc Nephrol, 2008, 19(5):1034-1040.
|
| 25 |
Buffington DA, Pino CJ, Chen L, et al. Bioartificial renal epithelial cell system (BRECS): A compact, cryopreservable extracorporeal renal replacement device [J]. Cell Med, 2012, 4(1):33-43.
|
| 26 |
Döcke WD, Randow F, Syrbe U, et al. Monocyte deactivation in septic patients: restoration by IFN-gamma treatment [J]. Nat Med, 1997, 3(6):678-681.
|
| 27 |
Caille V, Chiche JD, Nciri N, et al. Histocompatibility leukocyte antigen-D related expression is specifically altered and predicts mortality in septic shock but not in other causes of shock [J]. Shock, 2004, 22(6):521-526.
|
| 28 |
Kaufmann I, Hoelzl A, Schliephake F, et al. Polymorphonuclear leukocyte dysfunction syndrome in patients with increasing sepsis severity [J]. Shock, 2006, 26(3):254-261.
|
| 29 |
Carr R, Modi N, Doré C. G-CSF and GM-CSF for treating or preventing neonatal infections [J]. Cochrane Database Syst Rev, 2003, 3:CD003066.
|
| 30 |
Napolitano LM. Immune stimulation in sepsis: to be or not to be? [J]. Chest, 2005, 127(6):1882-1885.
|
| 31 |
Stanworth SJ, Massey E, Hyde C, et al. Granulocyte transfusions for treating infections in patients with neutropenia or neutrophil dysfunction [J]. Cochrane Database Syst Rev, 2005, 3:CD005339.
|
| 32 |
Safdar A, Hanna HA, Boktour M, et al. Impact of high-dose granulocyte transfusions in patients with cancer with candidemia: retrospective case-control analysis of 491 episodes of Candida species bloodstream infections [J]. Cancer, 2004, 101(12):2859-2865.
|
| 33 |
Mohan P, Brocklehurst P. Granulocyte transfusions for neonates with confirmed or suspected sepsis and neutropaenia [J]. Cochrane Database Syst Rev, 2003, 4:CD003956.
|
| 34 |
Sauer M, Altrichter J, Kreutzer HJ, et al. Extracorporeal cell therapy with granulocytes in a pig model of Gram-positive sepsis [J]. Crit Care Med, 2009, 37(2):606-613.
|
| 35 |
Altrichter J, Sauer M, Kaftan K, et al. Extracorporeal cell therapy of septic shock patients with donor granulocytes: a pilot study [J]. Crit Care, 2011, 15(2):R82.
|
| 36 |
Mitzner SR, Freytag J, Sauer M, et al. Use of human preconditioned phagocytes for extracorporeal immune support: introduction of a concept [J]. Ther Apher, 2001, 5(5):423-432.
|
| 37 |
Xie Q, Liu J, Gu Y, et al. Endothelial bioreactor ameliorates endotoxemia sepsis in swine [J]. Blood Purif, 2010, 29(3):252-258.
|
| 38 |
Ait-Oufella H, Maury E, Lehoux S, et al. The endothelium: physiological functions and role in microcirculatory failure during severe sepsis [J]. Intensive Care Med, 2010, 36(8):1286-1298.
|
| 39 |
Skibsted S, Jones AE, Puskarich MA, et al. Biomarkers of endothelial cell activation in early sepsis [J]. Shock, 2013, 39(5):427-432.
|
| 40 |
Aird WC. Endothelium as a therapeutic target in sepsis [J]. Curr Drug Targets, 2007, 8(4):501-507.
|
| 41 |
Brodsky SV, Yamamoto T, Tada T, et al. Endothelial dysfunction in ischemic acute renal failure: rescue by transplanted endothelial cells [J]. Am J Physiol Renal Physiol, 2002, 282(6):1140-1149.
|
| 42 |
Herrler T, Wang H, Tischer A, et al. Decompression of inflammatory edema along with endothelial cell therapy expedites regeneration after renal ischemia-reperfusion injury [J]. Cell Transplant, 2013, 22(11):2091-2103.
|